載入...
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life
Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS) remains controversial. This report describes the initial study design, baseline characteristics, and quality of life of patients enrolled in the FSGS Clinical Trial, a large multicenter randomized st...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3306823/ https://ncbi.nlm.nih.gov/pubmed/21178977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2010.485 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|